4-hydroxycyclophosphamide has been researched along with Cardiotoxicity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araújo, AM; Bastos, ML; Carvalho, F; Costa, VM; Dionísio, F; Duarte-Araújo, M; Guedes de Pinho, P | 1 |
| Kawano, Y; Kurauchi, K; Miyahara, E; Nishikawa, T; Okamoto, Y | 1 |
2 other study(ies) available for 4-hydroxycyclophosphamide and Cardiotoxicity
| Article | Year |
|---|---|
Cardiotoxicity of cyclophosphamide's metabolites: an in vitro metabolomics approach in AC16 human cardiomyocytes.
Topics: Acrolein; Antineoplastic Agents; Cardiotoxicity; Cell Line; Cyclophosphamide; Dose-Response Relationship, Drug; Humans; Immunosuppressive Agents; Metabolomics; Myocytes, Cardiac | 2022 |
Role of metabolites of cyclophosphamide in cardiotoxicity.
Topics: Acetylcysteine; Acrolein; Aldehyde Dehydrogenase; Animals; Apoptosis; Cardiotoxicity; Cardiotoxins; Cell Line; Cell Survival; Cyclophosphamide; Free Radical Scavengers; Immunosuppressive Agents; Myocytes, Cardiac; Phosphoramide Mustards; Rats; Reactive Oxygen Species | 2017 |